Form 4 for IDXX Idexx Laboratories
Accepted 2024-02-09 00:00:00 ET · period of report 2024-02-07 · accession 0000874716-24-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-09 | 2024-02-07 | IDXX | MCKEON BRIAN P | EVP, CFO, Treas | S - Sale+OE | $570.01 | -23.3K | 47.1K | -33% | -$13.30M |
| D | 2024-02-09 | 2024-02-07 | IDXX | MCKEON BRIAN P | EVP, CFO, Treas | M - OptEx | $141.60 | +23.3K | 53.0K | +78% | +$3.30M |
| D | 2024-02-09 | 2024-02-07 | IDXX | MCKEON BRIAN P | EVP, CFO, Treas | M - OptEx | — | -23.3K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-07 | S | D | 701 | $566.53 | 50,146.59 | D | — | — | (F4) Represents the weighted average price of the shares sold ranging from a low of $565.89 to a high of $566.84 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 2 | Common | Common Stock | 2024-02-07 | S | D | 1,581 | $564.98 | 50,847.59 | D | — | — | (F3) Represents the weighted average price of the shares sold ranging from a low of $564.63 to a high of $565.50 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 3 | Common | Common Stock | 2024-02-07 | S | D | 615 | $563.82 | 52,428.59 | D | — | — | (F2) Represents the weighted average price of the shares sold ranging from a low of $563.48 to a high of $564.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 4 | Common | Common Stock | 2024-02-07 | M | A | 23,326 | $141.60 | 53,043.59 | D | — | — | (F1) Includes a total of 25.247 shares purchased under the Issuer Employee Stock Purchase Plan on September 29, 2023 and December 29, 2023. |
| 5 | Common | Common Stock | 2024-02-07 | S | D | 3,912 | $569.91 | 43,201.59 | D | — | — | (F7) Represents the weighted average price of the shares sold ranging from a low of $569.34 to a high of $570.34 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 6 | Common | Common Stock | 2024-02-07 | S | D | 5,675 | $570.97 | 37,526.59 | D | — | — | (F8) Represents the weighted average price of the shares sold ranging from a low of $570.345 to a high of $571.34 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 7 | Common | Common Stock | 2024-02-07 | S | D | 7,128 | $571.84 | 30,398.59 | D | — | — | (F9) Represents the weighted average price of the shares sold ranging from a low of $571.36 to a high of $572.33 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 8 | Common | Common Stock | 2024-02-07 | S | D | 681 | $572.80 | 29,717.59 | D | — | — | (F10) Represents the weighted average price of the shares sold ranging from a low of $572.42 to a high of $573.09 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 9 | Common | Common Stock | 2024-02-07 | S | D | 1,564 | $567.35 | 48,582.59 | D | — | — | (F5) Represents the weighted average price of the shares sold ranging from a low of $566.92 to a high of $567.86 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 10 | Common | Common Stock | 2024-02-07 | S | D | 1,469 | $568.84 | 47,113.59 | D | — | — | (F6) Represents the weighted average price of the shares sold ranging from a low of $568.33 to a high of $569.28 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 11 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2024-02-07 | M | D | 23,326 | — | 0 | D | $141.60 · — to 2027-02-13 | 23,326 Common Stock | (F12) Not applicable. (F11) Grant of option to buy shares of Issuer common stock that vested in five annual installments beginning February 14, 2018. |